Literature DB >> 21620933

Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.

S S Mahajan1, K H Thai, K Chen, E Ziff.   

Abstract

AMPA receptors are glutamate receptors that are tetramers of various combinations of GluR1-4 subunits. AMPA receptors containing GluR1, 3 and 4 are Ca2+ permeable, however, AMPA receptors containing even a single subunit of GluR2 are Ca2+ impermeable. Most AMPA receptors are Ca2+ impermeable due to the presence of GluR2. GluR2 confers special properties on AMPA receptors through the presence of arginine at the pore apex; other subunits (GluR1, 3, 4) contain glutamine at the pore apex and allow Ca2+ influx. Normally, an RNA editing step changes DNA-encoded glutamine to arginine, introduces arginine in the GluR2 pore apex. GluR2 RNA editing is carried out by an RNA-dependent adenosine deaminase (ADAR2). Loss of GluR2 editing leads to the formation of highly excitotoxic AMPA channels [Mahajan and Ziff (2007) Mol Cell Neurosci 35:470-481] and is shown to contribute to loss of motor neurons in amyotrophic lateral sclerosis (ALS). Relatively higher levels of Ca2+-permeable AMPA receptors are found in motor neurons and this has been correlated with lower GluR2 mRNA levels. However, the reason for loss of GluR2 editing is not known. Here we show that exposure of neurons to excitotoxic levels of glutamate leads to specific cleavage of ADAR2 that leads to generation of unedited GluR2. We demonstrate that cleaved ADAR2 leads to a decrease or loss of GluR2 editing, which will further result in high Ca2+ influx and excitotoxic neuronal death. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620933      PMCID: PMC3150305          DOI: 10.1016/j.neuroscience.2011.05.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  63 in total

1.  Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice.

Authors:  R Brusa; F Zimmermann; D S Koh; D Feldmeyer; P Gass; P H Seeburg; R Sprengel
Journal:  Science       Date:  1995-12-08       Impact factor: 47.728

2.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

Review 4.  Cloned glutamate receptors.

Authors:  M Hollmann; S Heinemann
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

5.  Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain.

Authors:  M E Figueiredo-Pereira; N Banik; S Wilk
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

6.  Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro.

Authors:  S G Carriedo; H Z Yin; J H Weiss
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

7.  RED2, a brain-specific member of the RNA-specific adenosine deaminase family.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; M Higuchi; P H Seeburg
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

8.  A mammalian RNA editing enzyme.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; P H Seeburg; M Higuchi
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

9.  The role of zinc in selective neuronal death after transient global cerebral ischemia.

Authors:  J Y Koh; S W Suh; B J Gwag; Y Y He; C Y Hsu; D W Choi
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

10.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; G Tsai; R W Kuncl; L Clawson; D R Cornblath; D B Drachman; A Pestronk; B L Stauch; J T Coyle
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

View more
  20 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 2.  ADAR RNA editing in human disease; more to it than meets the I.

Authors:  Angela Gallo; Dragana Vukic; David Michalík; Mary A O'Connell; Liam P Keegan
Journal:  Hum Genet       Date:  2017-09-14       Impact factor: 4.132

3.  Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.

Authors:  Daniela Bonini; Alice Filippini; Luca La Via; Chiara Fiorentini; Fabio Fumagalli; Marina Colombi; Alessandro Barbon
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 4.  EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.

Authors:  Lauren Taylor Rosenblum; Davide Trotti
Journal:  Adv Neurobiol       Date:  2017

5.  Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression.

Authors:  Giannina Descalzi; Vasiliki Mitsi; Immanuel Purushothaman; Sevasti Gaspari; Kleopatra Avrampou; Yong-Hwee Eddie Loh; Li Shen; Venetia Zachariou
Journal:  Sci Signal       Date:  2017-03-21       Impact factor: 8.192

Review 6.  Evaluating a Gene-Environment Interaction in Amyotrophic Lateral Sclerosis: Methylmercury Exposure and Mutated SOD1.

Authors:  Jordan M Bailey; Alexandra Colón-Rodríguez; William D Atchison
Journal:  Curr Environ Health Rep       Date:  2017-06

Review 7.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

Review 8.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

9.  Calcium-permeable AMPA receptors in neonatal hypoxic-ischemic encephalopathy (Review).

Authors:  Xiao-Juan Tang; Feng Xing
Journal:  Biomed Rep       Date:  2013-07-30

10.  ADAR2-mediated Q/R editing of GluK2 regulates kainate receptor upscaling in response to suppression of synaptic activity.

Authors:  Sonam Gurung; Ashley J Evans; Kevin A Wilkinson; Jeremy M Henley
Journal:  J Cell Sci       Date:  2018-12-17       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.